Yoshitaka Imura
Overview
Explore the profile of Yoshitaka Imura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1018
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watanabe T, Taniguchi M, Ogura S, Asou M, Takayanagi S, Sokai Y, et al.
Ther Apher Dial
. 2024 Jan;
28(3):432-441.
PMID: 38225794
Introduction: Clinically amyopathic dermatomyositis (CADM) with anti-melanoma differentiation-associated gene 5 (MDA5) antibody (Ab) with rapidly progressive interstitial lung disease (RP-ILD) is often refractory for intensive immunosuppression. In this study, we...
2.
Sasai T, Nakashima R, Tsuji H, Nakajima T, Imura Y, Yoshida Y, et al.
J Rheumatol
. 2023 Sep;
50(11):1454-1461.
PMID: 37714541
Objective: Antimelanoma differentiation-associated gene 5 (anti-MDA5)-positive dermatomyositis with interstitial lung disease (DM-ILD) progresses rapidly and has a poor prognosis. Previously, we reported the efficacy of a combination therapy comprising high-dose...
3.
Kitajima T, Funauchi A, Nakajima T, Marumo S, Imura Y, Fukui M
J Rheumatol
. 2022 Oct;
50(2):295-296.
PMID: 36182109
No abstract available.
4.
Kitajima T, Funauchi A, Nakajima T, Marumo S, Imura Y, Fukui M
J Rheumatol
. 2022 Jun;
49(10):1158-1162.
PMID: 35705246
Objective: Melanoma differentiation-associated gene 5 (MDA5) is a viral RNA sensor induced by SARS-CoV-2. Similarities have been reported between the clinical presentations of coronavirus disease 2019 (COVID-19) pneumonia and anti-MDA5...
5.
Kimura N, Kawahara T, Uemura Y, Atsumi T, Sumida T, Mimura T, et al.
Rheumatology (Oxford)
. 2022 Feb;
61(11):4445-4454.
PMID: 35179548
Objectives: To assess the efficacy and safety of branched chain amino acids (BCAAs) in the treatment of PM/DM prior to official approval of their use in Japan. Methods: Treatment naïve...
6.
Iwasaki T, Nakabo S, Terao C, Murakami K, Nakashima R, Hashimoto M, et al.
Arthritis Res Ther
. 2020 Oct;
22(1):248.
PMID: 33076960
Background: The anti-cyclic citrullinated peptide (CCP) antibody is a diagnostic biomarker of rheumatoid arthritis (RA). However, some non-RA connective tissue disease (CTD) patients also test positive for the anti-CCP antibody...
7.
Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, et al.
Arthritis Rheumatol
. 2019 Sep;
72(3):488-498.
PMID: 31524333
Objective: Interstitial lung disease (ILD) accompanied by anti-melanoma differentiation-associated gene 5 (anti-MDA-5)-positive dermatomyositis (DM) is often rapidly progressive and associated with poor prognosis. Because there is no established treatment, we...
8.
Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, et al.
Mod Rheumatol
. 2017 Oct;
28(4):626-636.
PMID: 28972439
Objectives: Suppressor of TCR signaling-2 (STS-2) is one of the RA susceptibility genes identified in genome-wide association studies (GWAS). We tried to verify the involvement of STS-2 on the development...
9.
Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, et al.
Arthritis Res Ther
. 2017 Sep;
19(1):197.
PMID: 28874185
Background: A previous study revealed the association between susceptibility to Takayasu arteritis (TAK) and a single nucleotide polymorphism (SNP) rs6871626 located in IL12B, which encodes interleukin (IL)-12p40, a common component...
10.
Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, et al.
Sci Rep
. 2017 Aug;
7(1):6911.
PMID: 28761166
Anti-centromere antibody (ACA) is one of the classical anti-nuclear antibody (ANA) staining patterns. However, characteristics of ACA in comparison with the other ANA patterns and clinical features of ACA-positive subjects...